MedPath
NMPA Approval

Oseltamivir Phosphate for Suspension

国药准字H20233382

May 9, 2023

Drug Information

磷酸奥司他韦干混悬剂

口服混悬剂

0.36g(按C₁₆H₂₈N₂O₄ 计)

化学药品

May 9, 2023

Company Information

Applicant Company

南京市麒麟科技创新园耀园路8号5楼

Manufacturing Company

北辰科技园区华实道88号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

磷酸奥司他韦干混悬剂 - NMPA 批准文号 | MedPath